ONDO is trading at $0.463319, down 6.60% over 24 hours and 7.21% over seven days. The current price is only about 0.7% above the daily low of $0.460222 and roughly 7.7% of the way from the daily low to the $0.500628 high, showing that the price is near the bottom of its reported daily range.

The short-term moving-average picture is bearish: price is below every listed hourly average, from the 8-period SMA at $0.4650 to the 144-period SMA at $0.4924. The gap ranges from 0.37% below the shortest average to 5.90% below the longest, indicating weakness across the supplied hourly averages rather than a decline confined to one reading.

Momentum readings reinforce that caution but are not extreme. The 1-hour RSI of 44 and 7-day RSI of 46 are below the neutral midpoint of 50, consistent with modest downside momentum; neither reading, however, indicates an oversold condition based on the supplied values.

The longer-period price changes conflict with the recent weakness. ONDO is up 13.77% over 14 days and 22.98% over 30 days, so the sharp daily and weekly declines have occurred alongside positive performance over those broader windows; those gains temper, but do not erase, the negative near-term signals.

Volume is 191,394,373, with volume equal to 8.48% of market capitalization. This provides a measure of trading activity relative to market size, but without comparable historical volume or buy/sell flow data it does not establish whether participation is unusually high or predominantly one-sided.

ONDO remains substantially below its $2.14 all-time high, last recorded on December 15, 2024. That distance is a historical price comparison, not by itself evidence of a recovery catalyst or a defined support level, and the supplied data does not identify either.

The overall rating is Hold. The close-to-low daily position, negative 24-hour and seven-day changes, sub-50 RSI readings, and price below all listed moving averages make the immediate picture bearish, while the positive 14-day and 30-day returns argue against treating the supplied evidence as uniformly negative.

The primary reason for Hold rather than Buy is that the short-term technical and price signals do not yet confirm renewed strength. The primary reason against Sell is that performance over two and four weeks remains positive, leaving a meaningful conflict in the evidence; confirmation from price moving back above the listed averages would be needed to improve the short-term assessment.